I was asked by the Dallas Morning News to predict future biotech controversies, in a similar way as did the San Francisco Chronicle, published last week and linked here earlier. Here is the somewhat different version that appeared today in Texas. (Registration may be required.)
Comments are visible to subscribers only. Log in or subscribe to join the conversation.
